ENOV Stock Analysis: Buy, Sell, or Hold?
ENOV - Enovis Corporation
$29.15
-0.15 (-0.51%)
▼
5d:
+7.84%
30d:
+45.46%
90d:
+24.36%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Get Alerted When ENOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ENOV shows positive signals but monitor for confirmation. Market pricing in 3.3% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: ENOV shows positive signals but monitor for confirmation. Market pricing in 3.3% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.90
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$24.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ENOV is currently trading at $29.15, which is considered extended relative to its 30-day fair value range of $22.75 to $28.29. The stock's valuation (Forward PE: 7.1) is in line with its historical norms (6.5). At these levels, the market is pricing in 3.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ENOV is in a uptrend. Immediate support is located at $25.40, while resistance sits at $30.52.
Market Sentiment: ENOV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $41.58 (+42.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ENOV is in a uptrend. Immediate support is located at $25.40, while resistance sits at $30.52.
Market Sentiment: ENOV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $41.58 (+42.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$22.75 -
$28.29
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.7% below Wall St target ($41.58)
- NEUTRAL: Market pricing in 3.3% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$22.75 -
$28.29
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$25.40
Resistance Level
$30.53
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.14
Wall Street Target
$41.58
(+42.7%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
153.1%
Profit Margin
-49.9%
Valuation Premium vs History
+3.3% premium
PE vs Historical
7.1 vs 6.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.3%
(market-implied from PE analysis)
1-Year Target
$30.11
(+3%)
2-Year Target
$31.11
(+7%)
3-Year Target
$32.13
(+10%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
PE COMPRESSION
$29.23
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 12.0%)
$118.79
(+308%)
Base:
(SPY PE: 7.1, Growth: 12.0%)
$40.94
(+41%)
Bear:
(PE: 6.1, Growth: 12.0%)
$34.80
(+19%)
Share & Embed Analysis
Last updated: August 02, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENOV showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Oliver Engert
BUY
1000 shares
2026-03-13
Oliver Engert
BUY
1000 shares
2026-03-09
Oliver Engert
BUY
750 shares
2026-03-06
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$72 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$86 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$238 | 51 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 60 HOLD |
